7e68ed4c8b7981adb8f307943b5d27c6 7e68ed4c8b7981adb8f307943b5d27c6

“I am only one,

But still I am one.

I cannot do everything,

But still I can do something;

And because I cannot do everything,

I will not refuse to do the something that I can do.”

imageedit_11_9594011861

Solving Kids' Cancer

"Solving Kids’ Cancer supports families affected by high-risk childhood cancers in the areas of neuroblastoma, brain tumours and sarcomas. We fund the next generation of innovative research in these challenging areas. We also offer a range of family support services to help inform and support families faced with childhood cancer.

 

Family Support Services

We provide support services to families affected by high risk childhood cancers, which take into consideration all of the aspects and pressures that are involved with the disease.

 

Access to Treatment

We are working closely with the experts responsible for clinical trials and innovative treatments both in the UK and overseas. We want the very best, cutting edge treatments to be accessible to UK families for free."

 

Donations

All donations are paid into Solving Kids' Cancer’s general funds to fund our general charitable activities. Our charitable activities include funding a child’s treatment against neuroblastoma, as well as sponsoring research and promoting education and awareness of neuroblastoma.

 

For more information on the charity, and to read some of the children's stories, visit their website via the link below.

solving-kids-cancer-carealine

Charity Registration No. 1135601

Please read Stella's story as an example of how SKC's fundraising can help save lives.

Stella's Story

Stella's story is also an example of how dinutuximab antibody therapy is a much needed therapy approved by the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe and is now the standard treatment for children with high-risk neuroblastoma in many countries.

 

 

 

However the UK's National Institute for Health and Care Excellence (NICE) have denied access to the therapy on the NHS.

 

 

 

"NICE based their decision on an annual cost to the NHS projected at just over £2m to give these children a greater chance of survival and a full and normal life.

 

 

 

In future, UK children diagnosed with high-risk neuroblastoma will need to join a clinical trial to benefit from antibody therapy, which is frankly unethical when an effective drug has been approved. The only alternative will be for parents to raise in excess of £500,000, as well as enormous reserves of emotional resilience and determination, to take their sick child abroad for the greater chance of survival dinutuximab therapy provides."  

 

Steve Richards, CEO of Solving Kids’ Cancer

 

 

 

You can help fight this decision.  This link will give you the details and tell you how you can help:

 

SKC